Tag: Pseudomonas aeruginosa
Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different Pathways, Different Signaling
Gabriel Torrensa, Sara Belén Hernándezb, Juan Alfonso Ayalac, Bartolome Moyaa, d, Carlos Juana, Felipe Cavab, Antonio Olivera aServicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Instituto de Investigación Sanitaria de Baleares (IdISBa), Palma, Spain. bLaboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden… Read More ›
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
Del Barrio-Tofiño E1, Sánchez-Diener I1, Zamorano L1, Cortes-Lara S1, López-Causapé C1, Cabot G1, Bou G2, Martínez-Martínez L3, Oliver A1; GEMARA-SEIMC/REIPI. 1Servicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Instituto de Investigación Sanitaria de les Illes Balears (IdISBa), Palma de Mallorca, Spain. 2Servicio de Microbiología, Hospital Universitario La Coruña, Instituto Investigación Biomédica A Coruña… Read More ›
Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
Sánchez-Diener I1, Zamorano L2, Peña C3, Ocampo-Sosa A4, Cabot G1, Gómez-Zorrilla S5, Almirante B6, Aguilar M7, Granados A8, Calbo E9, Baño JR10, Rodríguez-López F11, Tubau F12, Martínez-Martínez L11, Navas A13, and Oliver A14. 1Servicio de Microbiología and Unidad de Investigación, Hospital Son Espases, Instituto de Investigación Sanitaria de les Illes Balears (IdISBa), Palma de Mallorca,… Read More ›
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
Del Barrio-Tofiño E1, Zamorano L1, Cortés-Lara S1, Sánchez-Diener I1, Cabot G1, Bou G2, Martínez-Martínez L3 and Oliver A1; GEMARA-SEIMC/REIPI Pseudomonas study group 1Hospital Universitario Son Espases,Palma de Mallorca,Spain. 2Servicio de Microbiología, Hospital Universitario La Coruña, Instituto Investigación Biomédica A Coruña (INIBIC), La Coruña, España. 3Unidad de Gestión Clínica de Microbiología, Hospital Reina Sofía, Departamento de… Read More ›
O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones.
Mulet X1, García R1, Gayá M1, and Oliver A1 1Hospital Universitario Son Espases,Palma de Mallorca,Spain. Abstract: The increasing prevalence of extensively drug-resistant (XDR) Pseudomonas aeruginosa infections is due to the global spread of defined high-risk clones (HRC). Among them, ST175 is particularly frequent in Spain and France. Here, we evaluated O-antigen serotyping and MALDI-TOF as… Read More ›
V IdISBa Sessions – V Jornadas IdISBa
We are attending to the V Jornades Institut d’Investigació Sanitària Illes Balears (IdISBa) which is going to be held in Hospital Son Espases (Palma), from November 29th to November 30th. You’re invited to come and see what we are presenting there: (Thursday, November 29th) Poster Session. Poster 5 – Recycling of Pseudomonas aeruginosa cell-wall and… Read More ›
22nd Congress of Spanish Society for Infectious Diseases and Clinic Microbiology (SEIMC) Attendance
We will be attending to the 22nd Congress of Spanish Society for Infectious Diseases and Clinic Microbiology (SEIMC, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica) which is going to be held in Bilbao, from May 24th to May 26th. You can come and see what we are presenting there: (Thursday, May 24th) Sesiones Orales… Read More ›
Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model.
Landersdorfer CB1,2, Rees VE3,2, Yadav R3, Rogers KE3,2, Kim TH4, Bergen PJ2, Cheah SE3, Boyce JD5, Peleg AY5,6, Oliver A7, Shin BS4, Nation RL3, Bulitta JB8. 1 Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia cornelia.landersdorfer@monash.edu. 2 Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash… Read More ›
Evolution of the Pseudomonas aeruginosa aminoglycoside mutational resistome in vitro and in the cystic fibrosis setting.
López-Causapé C1, Rubio R2, Cabot G2, Oliver A2. 1 Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa), Palma de Mallorca, Spain. carla.lopez@ssib.es. 2 Servicio de Microbiología and Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa),… Read More ›
Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.
Mensa J1, Barberán J2, Soriano A1, Llinares P3, Marco F4, Cantón R5, Bou G6, González Del Castillo J7, Maseda E8, Azanza JR9, Pasquau J10, García-Vidal C1, Reguera JM11, Sousa D3, Gómez J12, Montejo M13, Borges M14, Torres A15, Alvarez-Lerma F16, Salavert M17, Zaragoza R18, Oliver A19. 1Servicio de Enfermedades Infecciosas, Hospital Clinic, Barcelona, Spain 2Servicio… Read More ›
